Company profile
Chromition Digital Diagnostic Solutions - Home
Chromition-Digital Diagnostic Solutions enables the rapid, precise and cost-effective diagnosis of cancer, providing the optimal choice of personalised treatment, reducing costs for healthcare providers and better outcomes to enhance quality of life.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
AD01 | Transaction MzUzMDMzMzkxMmFkaXF6a2N4
Published 03 Jul 2026 13:28
SH03 | Transaction MzUyNjIyMzE3MGFkaXF6a2N4 | Paper/PDF filed
Published 19 Jun 2026 16:15
SH06 | Transaction MzUyMzI1MjM5OGFkaXF6a2N4 | Paper/PDF filed
Published 07 Jun 2026 22:40
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Chromition supply proprietary Luminspheres (photoluminescent), Elecspheres (semiconductor) & Dielecspheres (dielectric) nanoparticle solutions and collaborate with application developers to enable the realisation of next-generation technologies.
Chromition develops technology utilising nanoparticles for multiple applications including scientific imaging and electrical circuits. It also works in collaboration with independent researchers to develop new technologies.
Finalist in the RSC Emerging Technologies Competition 2015, 2018
1 Apr 2025 to 31 Mar 2026
The DEVOTE programme is helping to bring cutting-edge genetic testing into everyday healthcare in Greater Manchester. By combining expertise from universities, hospitals, and businesses, it has already started improving patient care by making genetic testing a routine part of diagnosis and treatment. The next phase of DEVOTE will continue working with ind...
1 May 2024 to 31 Oct 2026
Chromition's 'Digital Rapid Autonomous Cancer Screening' (DRACS) project will transform the way breast cancer is diagnosed. DRACS enables earlier diagnosis of breast cancer for patients to commence treatment sooner for improved quality of life and survival. Breast cancer patients require expert pathologist visual microscopic-assessment of a tissue biopsy ...
1 Apr 2023 to 31 Mar 2025
A biomarker is a chemical or signal which can be measured from the human body to help to diagnose disease or predict future health states. Biomarkers are commonly used in healthcare to guide patient management, but there is a major translational bottleneck between the discovery of a clinically relevant biomarker and its implementation in routine practice ...
1 Mar 2021 to 31 Aug 2023
Chromition's 'Digital Histopathology Screening Platform' (DHSP) will transform the way cancer is diagnosed in tissue biopsies taken from patients. The DHSP will enable the autonomous, rapid, economical diagnosis of cancer in tissue and provide a more detailed picture of disease status and enable stratification of patients for physicians to provide persona...
1 Aug 2017 to 31 Jul 2019
The project will develop and validate a method for automatically analysing cellular patterns, labelled by immunohistochemistry. Currently, pathologists visually assess tissue samples in order to diagnose diseases such as cancer and provide a prognosis. Currently a maximum of three biomarkers can be analysed at one time. Analysing multiple biomarkers provi...
1 May 2017 to 30 Apr 2018
The global Light Emitting Diode (LED) market is forecast to reach $105.5 billion by 2019. Currently, the main applications for LEDs are energy efficient lighting and backlighting for displays used in smart phones, personal computers and televisions. State of the art LED technology relies on the use of rare earth minerals as a source of phosphor. China has...
